These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10349787

  • 1. [Non-immunoallergic hepatotoxicity due to mesalazine].
    Barroso N, Leo E, Guil A, Larrauri J, Tirado C, Zafra C, Gavilán F, Reina FR.
    Gastroenterol Hepatol; 1999 Apr; 22(4):176-9. PubMed ID: 10349787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mesalamine-induced granulomatous hepatitis.
    Braun M, Fraser GM, Kunin M, Salamon F, Tur-Kaspa R.
    Am J Gastroenterol; 1999 Jul; 94(7):1973-4. PubMed ID: 10406274
    [Abstract] [Full Text] [Related]

  • 4. [Mesalazine-induced acute hepatitis].
    Domínguez Jiménez JL, Pelado García EM, Copado Herrera R.
    Gastroenterol Hepatol; 2015 Apr; 38(4):302-3. PubMed ID: 25458543
    [No Abstract] [Full Text] [Related]

  • 5. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Ransford RA, Langman MJ.
    Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. "Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug".
    Garrido I, Santos AL, Lopes J, Lopes S, Macedo G.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e1067-e1070. PubMed ID: 35048663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB, Klemt-Kropp M.
    Ned Tijdschr Geneeskd; 2011 Dec 01; 155(48):A3842. PubMed ID: 22152414
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effect of mesalazine and sulfasalazine on laboratory parameters: a retrospective observational study.
    Masuda H, Takahashi Y, Nishida Y, Asai S.
    Eur J Clin Pharmacol; 2012 Nov 01; 68(11):1549-55. PubMed ID: 22546896
    [Abstract] [Full Text] [Related]

  • 15. [Interstitial pneumonia related to mesalamine].
    Lamsiah T, Moudden K, Baaj M, Hadri L.
    Gastroenterol Clin Biol; 2010 Mar 01; 34(3):224-6. PubMed ID: 20299168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
    Machida H, Shinohara T, Hatakeyama N, Inayama M, Hosokawa E, Ogushi F.
    Nihon Kokyuki Gakkai Zasshi; 2011 Jul 01; 49(7):538-42. PubMed ID: 21842693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic interstitial nephritis and mesalazine: 3 new cases?].
    Brouillard M, Gheerbrant JD, Gheysens Y, Fleury D, Devred M, Hazzan M, Colombel JF.
    Gastroenterol Clin Biol; 1998 Jul 01; 22(8-9):724-6. PubMed ID: 9823562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.